Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Drug Merger Boom Sends Hedging Costs to Eight-Year High
Drug Merger Boom Sends Hedging Costs to Eight-Year High
Drug Merger Boom Sends Hedging Costs to Eight-Year High
Submitted by
admin
on April 30, 2014 - 8:39am
Source:
Bloomberg
News Tags:
M&A
Gilead Sciences
Forest Labs
Pfizer
Allergan
Eli Lilly
Headline:
Drug Merger Boom Sends Hedging Costs to Eight-Year High
Do Not Allow Advertisers to Use My Personal information
